PP405 is a new hairloss treatment in phase 2 trials that may promote hair growth by increasing lactate production and activating hair follicle stem cells. It could potentially replace hormone-disrupting treatments like Minoxidil and finasteride.
CRISPR shows promise for treating hairloss by targeting specific genes. Current treatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.
The conversation discusses the potential link between gut health and hairloss, with personal experiences of hair thinning and stomach issues shared. Some individuals found no success with common hairloss treatments like Minoxidil and Finasteride and are exploring the impact of gut health on hair growth.
A user named "EgyptStar81" who has been dealing with hairloss since age 15 due to genetics, chemotherapy and finasteride/minoxidil treatment. Possible solutions such as dutasteride, oral minoxidil, hair transplants and extensions were suggested.
The user claims NoFap (abstaining from pornography, masturbation, and orgasm) helped stop their hairloss. Others argue that hairloss is primarily due to genetics and DHT, which can be managed with finasteride.